In the attempt to shed light on the process involved in Notch/NF-κB combined enhancement of MDSCs, we observed that it coincided with the considerable increase in the level of IL-6, which represents a major regulator of MDSC activity in cancer [58]. The gene discussed is NFKB1; the disease is cancer.